Put Antipsychotics for Agitation in Dementia in Perspective

September 2023

You may see some patients admitted on brexpiprazole (Rexulti) to treat agitation in dementia.

Brexpiprazole is an oral second-generation antipsychotic already approved for schizophrenia and as an add-on for depression.

Now you’ll hear that brexpiprazole is the first med FDA-approved for agitation in patients with Alzheimer’s dementia.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote